Targeting protein-protein interaction interfaces in COVID-19 drug discovery
To date, the COVID-19 pandemic has claimed over 1 million human lives, infected another 50 million individuals and wreaked havoc on the global economy.The crisis has spurred the ongoing development of drugs targeting its etiological agent, the SARS-CoV-2.Targeting relevant protein-protein interaction jerome brown jersey interfaces (PPIIs) is a viab